These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11980636)

  • 1. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.
    Mabjeesh NJ; Post DE; Willard MT; Kaur B; Van Meir EG; Simons JW; Zhong H
    Cancer Res; 2002 May; 62(9):2478-82. PubMed ID: 11980636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
    Schwock J; Geddie WR; Hedley DW
    Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
    Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
    Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
    Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
    Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion.
    Zagzag D; Nomura M; Friedlander DR; Blanco CY; Gagner JP; Nomura N; Newcomb EW
    J Cell Physiol; 2003 Aug; 196(2):394-402. PubMed ID: 12811834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
    Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG
    Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
    Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH
    Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells.
    Zhong H; Hanrahan C; van der Poel H; Simons JW
    Biochem Biophys Res Commun; 2001 Jun; 284(2):352-6. PubMed ID: 11394885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway.
    Isaacs JS; Jung YJ; Neckers L
    J Biol Chem; 2004 Apr; 279(16):16128-35. PubMed ID: 14764593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.
    Suzuki H; Tomida A; Tsuruo T
    Oncogene; 2001 Sep; 20(41):5779-88. PubMed ID: 11593383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
    Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
    Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
    Thomas R; Kim MH
    Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin.
    Ma Y; Lakshmikanthan V; Lewis RW; Kumar MV
    Mol Cancer Ther; 2006 Jan; 5(1):170-8. PubMed ID: 16432176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
    Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
    Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle.
    Milkiewicz M; Doyle JL; Fudalewski T; Ispanovic E; Aghasi M; Haas TL
    J Physiol; 2007 Sep; 583(Pt 2):753-66. PubMed ID: 17627993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.